A Different Approach to Neurorehabilitation
At COSYMA, we focus on restoring function by engaging the body's existing neural networks rather than replacing movement with external mechanical systems.
Our work is based on the principle that even after spinal cord injury, stroke, or cerebral palsy, significant portions of the nervous system often remain anatomically intact. Through targeted non-invasive spinal neuromodulation combined with activity-based rehabilitation, these neural circuits may be reactivated and retrained to support functional recovery.
Rather than replacing biological function, our goal is to help clinicians harness the nervous system's inherent capacity for neuroplasticity.
At COSYMA, we focus on restoring function by engaging the body's existing neural networks rather than replacing movement with external mechanical systems.
Our work is based on the principle that even after spinal cord injury, stroke, or cerebral palsy, significant portions of the nervous system often remain anatomically intact. Through targeted non-invasive spinal neuromodulation combined with activity-based rehabilitation, these neural circuits may be reactivated and retrained to support functional recovery.
Rather than replacing biological function, our goal is to help clinicians harness the nervous system's inherent capacity for neuroplasticity.
Science-Driven Neurorehabilitation
At COSYMA, we believe that recovery begins with understanding how the nervous system works.
Our technologies are founded on decades of research into spinal cord neurophysiology, neural plasticity, and neuromodulation. By combining scientific discovery with clinical insight, we have developed a platform of non-invasive spinal stimulation technologies that support modern neurorehabilitation and functional recovery.
Working at the intersection of neuroscience, engineering, and rehabilitation medicine, our team develops solutions designed to help clinicians activate and train neural networks involved in movement, posture, respiration, and other essential functions.
The result is a rehabilitation approach that leverages the body's own neural pathways to support recovery, improve functional outcomes, and expand possibilities for individuals living with neurological injury or disease.
Learn More Our technologies are founded on decades of research into spinal cord neurophysiology, neural plasticity, and neuromodulation. By combining scientific discovery with clinical insight, we have developed a platform of non-invasive spinal stimulation technologies that support modern neurorehabilitation and functional recovery.
Working at the intersection of neuroscience, engineering, and rehabilitation medicine, our team develops solutions designed to help clinicians activate and train neural networks involved in movement, posture, respiration, and other essential functions.
The result is a rehabilitation approach that leverages the body's own neural pathways to support recovery, improve functional outcomes, and expand possibilities for individuals living with neurological injury or disease.
Tomorrow
Today
We create a new standard of highly efficient and affordable rehabilitation
Yesterday
Together we accomplish your dream
An international scientific team led by Yury Gerasimenko has developed a non-invasive technique for restoring movements for patients with spinal cord injury.
The technique is based on a breakthrough technology of non-invasive neurostimulation of the spinal cord.
The technique is based on a breakthrough technology of non-invasive neurostimulation of the spinal cord.
A New Strategy for Functional Recovery
Research over the past decade has demonstrated that spinal neural networks can generate and modulate complex motor patterns when appropriately activated.
From habilitation to rehabilitation
The objective is to facilitate neuroplasticity changes within spinal and supraspinal networks that may contribute to improvements in motor control, walking function, and autonomic regulation.
Tomorrow
Today
We create a new standard of highly efficient and affordable rehabilitation
Yesterday
Together we accomplish your dream
An international scientific team led by Yury Gerasimenko has developed a non-invasive technique for restoring movements for patients with spinal cord injury.
The technique is based on a breakthrough technology of non-invasive neurostimulation of the spinal cord.
The technique is based on a breakthrough technology of non-invasive neurostimulation of the spinal cord.
A new strategy for neurorehabilitation
We have learned not only to start the movement of the affected function, but also to control it. Multilevel spinal cord stimulation combined with locomotor training is the basis of the new strategy.
From habilitation to rehabilitation
The latest results of researches of our team give every reason to believe in the possibility of restoring motor function, not replacing it with prostheses, exoskeletons or wheelchairs. The trend is turning from habilitation to rehabilitation. That will dramatically change the lives of millions of patients with SCI and cerebral palsy.
From Compensation Toward Recovery
Traditional rehabilitation frequently relies on compensatory strategies and assistive technologies to maximize independence.
Emerging research in neuromodulation suggests that, for some individuals, targeted activation of neural circuits may promote functional improvements beyond compensation alone.
While significant challenges remain and outcomes vary among patients, ongoing studies indicate that non-invasive spinal neuromodulation may become an important component of future neurorehabilitation programs for individuals with:
Traditional rehabilitation frequently relies on compensatory strategies and assistive technologies to maximize independence.
Emerging research in neuromodulation suggests that, for some individuals, targeted activation of neural circuits may promote functional improvements beyond compensation alone.
While significant challenges remain and outcomes vary among patients, ongoing studies indicate that non-invasive spinal neuromodulation may become an important component of future neurorehabilitation programs for individuals with:
- Spinal cord injury (SCI)
- Stroke
- Cerebral palsy (CP)
- Other neurological movement disorders
Just take a look how we use our devices
About COSYMA
Founded in 2010, COSYMA has been a scientific and engineering company dedicated to the development of advanced neuromodulation technologies.
The company brings together specialists in:
In 2022 the company moved to Thailand and was registered in Bangkok under the name Nero Rehab Technology Co., Ltd. (NRT).
Learn More The company brings together specialists in:
- Neurophysiology
- Biomedical engineering
- Rehabilitation medicine
- Clinical neuroscience
In 2022 the company moved to Thailand and was registered in Bangkok under the name Nero Rehab Technology Co., Ltd. (NRT).
- 20 yearsof fundamental and clinical research — making movement restoration possible without surgery
- 500,000 Peopleface spinal cord injuries each year — and gain a chance to restore function
- from 70% to 36%the share of patients completely dependent on assistance decreases
- 70%patients achieve their individual functional rehabilitation goals
- 98,3%patients show a motor response to stimulation, confirming the high reproducibility of the method
- 130+scientific publications
10%
have access to efficient rehabilitation technologies
In total
Only 10%
Only 10%
Making our best to help patients with SCI and cerebral palsy all around the globe
badly need
motor rehabilitation
motor rehabilitation
18 million people
Making our best to help patients with SCI and cerebral palsy all around the globe
10%
have access to efficient
rehabilitation technologies
rehabilitation technologies
In total
Only 10%
Only 10%
badly need
motor rehabilitation
motor rehabilitation
18 million people
Making our best to help patients with SCI and cerebral palsy all around the globe
10%
have access to efficient
rehabilitation technologies
rehabilitation technologies
In total
Only 10%
Only 10%
badly need
motor rehabilitation
motor rehabilitation
18 million people
Expanding the Scope of Neurorehabilitation
Current areas of investigation include:
- Respiratory function
- Cardiovascular regulation
- Bladder function
- Bowel function
- Motor coordination
- Spasticity management
Recent studies involving individuals with stroke and cerebral palsy have reported improvements in gait characteristics, motor control, and functional mobility when spinal stimulation is combined with rehabilitation training.
These findings remain an active area of research, and further clinical studies are needed to determine long-term efficacy, optimal treatment protocols, and patient selection criteria.
Although restoration of walking function remains a primary focus, growing evidence suggests that spinal neuromodulation may influence neural circuits involved in autonomic regulation.
Global strategy of neurorehabilitation
Current areas of investigation include:
- Respiratory function
- Cardiovascular regulation
- Bladder function
- Bowel function
- Motor coordination
- Spasticity management
Recent studies involving individuals with stroke and cerebral palsy have reported improvements in gait characteristics, motor control, and functional mobility when spinal stimulation is combined with rehabilitation training.
These findings remain an active area of research, and further clinical studies are needed to determine long-term efficacy, optimal treatment protocols, and patient selection criteria.
Although restoration of walking function remains a primary focus, growing evidence suggests that spinal neuromodulation may influence neural circuits involved in autonomic regulation.
Our Devices
-
NeoStim‑C.5
Multisite Transcutaneous Spinal Stimulation Research System
NeoStim-C.5 is a multi-channel research platform designed to deliver non-invasive spinal stimulation through five independently controlled channels. -
NeoStim‑C.6
Advanced Multisite Spinal Neuromodulation Research System
NeoStim-C.6 is designed to provide continuous or rhythmic transcutaneous stimulation of cervical and lumbosacral spinal networks. -
NeoStim‑16
Functional Electrical Stimulation (FES) System
NeoStim-16 delivers transcutaneous electrical stimulation to peripheral nerves and muscles during functional movement tasks.
-
Spinal Neuroprosthesis
Portable Neuromodulation Platform
The Spinal Neuroprosthesis is a portable neuromodulation system designed to support activity-based rehabilitation through non-invasive spinal stimulation. -
BioKin‑ES APC
Integrated Rehabilitation and Neuromodulation Platform
BioSkin-ES APC combines robotic-assisted movement training with spinal neuromodulation and functional electrical stimulation.
NeoStim-С.5
Multisite Transcutaneous Spinal Stimulation Research System
NeoStim-C.5 is a multi-channel research platform designed to deliver non-invasive spinal stimulation through five independently controlled channels.
Scientific Rationale
The system is designed to investigate how multisite transcutaneous spinal stimulation influences neural network excitability, spinal circuit activation, and activity-dependent neuroplasticity.
Research Applications
The system may be used in studies involving:
NeoStim-C.5 is FDA-cleared in Russia and Thailand and intended for diagnosis, treatment, or clinical use.
In other countries it can only be used for scientific and investigational applications only.
NeoStim-C.5 is a multi-channel research platform designed to deliver non-invasive spinal stimulation through five independently controlled channels.
Scientific Rationale
The system is designed to investigate how multisite transcutaneous spinal stimulation influences neural network excitability, spinal circuit activation, and activity-dependent neuroplasticity.
Research Applications
The system may be used in studies involving:
- Spinal cord injury
- Stroke
- Cerebral palsy
- Sports-related neurological injuries
- Military trauma
- Neurological impairments following spinal surgery
NeoStim-C.5 is FDA-cleared in Russia and Thailand and intended for diagnosis, treatment, or clinical use.
In other countries it can only be used for scientific and investigational applications only.
NeoStim-С.6
Advanced Multisite Spinal Neuromodulation Research System
NeoStim-C.6 is designed to provide continuous or rhythmic transcutaneous stimulation of cervical and lumbosacral spinal networks.
Research Focus
The system supports investigations into:
NeoStim-C.6 is FDA-cleared in Russia and Thailand and intended for diagnosis, treatment, or clinical use.
In other countries it can only be used for scientific and investigational applications only.
NeoStim-C.6 is designed to provide continuous or rhythmic transcutaneous stimulation of cervical and lumbosacral spinal networks.
Research Focus
The system supports investigations into:
- Motor recovery mechanisms
- Locomotor control
- Neuroplasticity
- Sensorimotor integration
- Autonomic nervous system regulation
NeoStim-C.6 is FDA-cleared in Russia and Thailand and intended for diagnosis, treatment, or clinical use.
In other countries it can only be used for scientific and investigational applications only.
NeoStim-16
Functional Electrical Stimulation (FES) System
NeoStim-16 delivers transcutaneous electrical stimulation to peripheral nerves and muscles during functional movement tasks.
Clinical and Research Applications
The system is designed to support:
Studies of functional electrical stimulation have demonstrated potential benefits including:
Regulatory Status
NeoStim-16 is FDA-cleared in Russia and Thailand and intended for diagnosis, treatment, or clinical use.
In other countries it can only be used for scientific and investigational applications only.
NeoStim-16 delivers transcutaneous electrical stimulation to peripheral nerves and muscles during functional movement tasks.
Clinical and Research Applications
The system is designed to support:
- Gait rehabilitation
- Cycling-based rehabilitation
- Repetitive task training
- Neuromuscular re-education
Studies of functional electrical stimulation have demonstrated potential benefits including:
- Improved gait mechanics
- Enhanced muscle activation
- Reduction in spasticity
- Improved motor coordination
- Increased patient participation in rehabilitation training
Regulatory Status
NeoStim-16 is FDA-cleared in Russia and Thailand and intended for diagnosis, treatment, or clinical use.
In other countries it can only be used for scientific and investigational applications only.
NeoStim-3
Multisite Transcutaneous Spinal Stimulation for Walking and Autonomic Recovery
Basic principles:
Multisite transcutaneous spinal stimulation induces neuroplasticity of the spinal networks.
Field of application:
Non-invasive electrical SCS is the cornerstone of an innovative technology for motor rehabilitation of paralyzed patients with spinal cord injury, cerebral palsy and after a stroke, based on fundamental physiological researches.
Functional possibilities:
- Recovery of locomotor and autonomic functions in people with chronic SCI
- Improved muscle sensation and bowel function
- Reduction of spasticity and improvement of walking coordination
- Improvement of genitourinary function
Spinal Neuroprosthesis
Portable Neuromodulation Platform
The Spinal Neuroprosthesis is a portable neuromodulation system designed to support activity-based rehabilitation through non-invasive spinal stimulation.
Unlike robotic systems that generate movement mechanically, this approach seeks to facilitate activation of the patient's own neuromuscular pathways during functional tasks.
Potential Applications
Spinal Neuroprosthesis is FDA-cleared in Russia and intended for diagnosis, treatment, or clinical use.
In other countries it can only be used for scientific and investigational applications only.
The Spinal Neuroprosthesis is a portable neuromodulation system designed to support activity-based rehabilitation through non-invasive spinal stimulation.
Unlike robotic systems that generate movement mechanically, this approach seeks to facilitate activation of the patient's own neuromuscular pathways during functional tasks.
Potential Applications
- Home-based rehabilitation
- Outpatient therapy
- Rehabilitation hospitals
- Research programs
- Lightweight portable design
- Multisite spinal stimulation
- Activity-based integration
- Potential support for gait training and functional mobility exercises
Spinal Neuroprosthesis is FDA-cleared in Russia and intended for diagnosis, treatment, or clinical use.
In other countries it can only be used for scientific and investigational applications only.
Spinal Neuroprosthesis
Integrated Rehabilitation and Neuromodulation Platform
BioSkin-ES APC combines robotic-assisted movement training with spinal neuromodulation and functional electrical stimulation.
The system is designed to support intensive, task-specific rehabilitation of both upper and lower extremities.
Intended Research Areas
Spinal Neuroprosthesis Regulatory Status
Spinal Neuroprosthesis is FDA-cleared in Russia and intended for diagnosis, treatment, or clinical use.
In other countries it can only be used for scientific and investigational applications only.
BioSkin-ES APC combines robotic-assisted movement training with spinal neuromodulation and functional electrical stimulation.
The system is designed to support intensive, task-specific rehabilitation of both upper and lower extremities.
Intended Research Areas
- Motor recovery after spinal cord injury
- Stroke rehabilitation
- Cerebral palsy rehabilitation
- Neuroplasticity studies
- Combined locomotor and neuromodulation interventions
Spinal Neuroprosthesis Regulatory Status
Spinal Neuroprosthesis is FDA-cleared in Russia and intended for diagnosis, treatment, or clinical use.
In other countries it can only be used for scientific and investigational applications only.
Patents
Publications
Collaborations
Collaborations
